Generic Pharmaceuticals: Patent Expiration and Low Global Utilization Rates Create Opportunities
Key Takeaways: · The generic pharmaceutical industry will benefit from a patent expiry “mountain” in 2015. · Penetration and utilization rates of generics vary considerably by country. Japan, Italy, Spain, France, and Australia are most likely to see the greatest increases in generic penetration rates. · We expect further M&A activity in Japan, as global players seek to gain a generics stronghold in this under-penetrated, yet burgeoning pharmaceutical market. · Emerging market growth will offer significant opportunities for firms levered to Latin America and South Africa. · The potential for biosimilars remains a key catalyst for the group. · Ideas o Teva Pharma (TEVA) is our favorite idea in the generics space thanks primarily to its upside valuation potential and global position. We’re particularly big fans … Read more